Show simple item record

dc.contributor.authorAraújo, Nuna
dc.contributor.authorViegas, Carla S. B.
dc.contributor.authorZubía Mendoza, Eva 
dc.contributor.authorMagalhães, Joana
dc.contributor.authorRamos, Acácio
dc.contributor.authorCarvalho, Maria M.
dc.contributor.authorCruz, Henrique
dc.contributor.authorSousa, João Paulo
dc.contributor.authorBlanco, Francisco J.
dc.contributor.authorVermeer, Cees
dc.contributor.authorSimes, Dina C.
dc.contributor.otherQuímica Orgánicaes_ES
dc.date.accessioned2021-02-01T10:38:36Z
dc.date.available2021-02-01T10:38:36Z
dc.date.issued2020-12
dc.identifier.issn1660-3397
dc.identifier.urihttp://hdl.handle.net/10498/24368
dc.description.abstractOsteoarthritis (OA) remains a prevalent chronic disease without effective prevention and treatment. Amentadione (YP), a meroditerpenoid purified from the alga Cystoseira usneoides, has demonstrated anti-inflammatory activity. Here, we investigated the YP anti-osteoarthritic potential, by using a novel OA preclinical drug development pipeline designed to evaluate the anti-inflammatory and anti-mineralizing activities of potential OA-protective compounds. The workflow was based on in vitro primary cell cultures followed by human cartilage explants assays and a new OA co-culture model, combining cartilage explants with synoviocytes under interleukin-1 beta (IL-1 beta) or hydroxyapatite (HAP) stimulation. A combination of gene expression analysis and measurement of inflammatory mediators showed that the proposed model mimicked early disease stages, while YP counteracted inflammatory responses by downregulation of COX-2 and IL-6, improved cartilage homeostasis by downregulation of MMP3 and the chondrocytes hypertrophic differentiation factors Col10 and Runx2. Importantly, YP downregulated NF-kappa B gene expression and decreased phosphorylated IkB alpha/total IkB alpha ratio in chondrocytes. These results indicate the co-culture as a relevant pre-clinical OA model, and strongly suggest YP as a cartilage protective factor by inhibiting inflammatory, mineralizing, catabolic and differentiation processes during OA development, through inhibition of NF-kappa B signaling pathways, with high therapeutic potential.es_ES
dc.formatapplication/pdfes_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.sourceMar. Drugs 2020, 18(12), 624es_ES
dc.subjectosteoarthritises_ES
dc.subjectamentadionees_ES
dc.subjectpreclinical osteoarthritis modelses_ES
dc.subjectmarine compoundses_ES
dc.subjectCystoseira usneoideses_ES
dc.subjectinflammationes_ES
dc.subjectmineralizationes_ES
dc.subjectchondrocyteses_ES
dc.subjectsynoviocyteses_ES
dc.subjectcartilage explantses_ES
dc.titleAmentadione from the Alga Cystoseira usneoides as a Novel Osteoarthritis Protective Agent in an Ex Vivo Co-Culture OA Modeles_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.3390/md18120624


Files in this item

This item appears in the following Collection(s)

Show simple item record

Atribución 4.0 Internacional
This work is under a Creative Commons License Atribución 4.0 Internacional